Table 3.
Microchannel type | Material type | Material size | Material shape | Porous type |
Bioapplication Area |
Ref by Year |
---|---|---|---|---|---|---|
Winding | SiO2 | 277–540 nm | Sphere | Solid | N/A | 200439 |
Winding | SiO2 | 200–300 nm | Sphere | Solid | N/A | 200440 |
Winding | SiO2@TiO2 | ~250 nm | Sphere | Solid | N/A | 200781 |
Cross-Winding | SiO2 | ~15–35 μm | Sphere | Mesopore (>5 nm) | N/A | 200882 |
T junction | SiO2 | 0.25–0.5 mm (Sphere); 1.1×2.3–4.7 mm (Rod) | Sphere; Rod | Solid | N/A | 200883 |
Cross junction | SiO2 | ~1 μm | Sphere | Mesopore (6.4 nm) | N/A | 200884 |
T junction | SiO2 | ~100 μm | Sphere | Hollow | N/A | 200985 |
Coflow and flow-focusing | SiO2 | ~50 μm | Nonsphere polygon | Hollow | N/A | 200986 |
Cross junction | SiO2 | 130 μm | Sphere | Hollow; mesopore (2 nm) | Iodine adsorption | 201087 |
Cross junction | SiO2-Chitosan | 250 μm | Sphere | Macropore | BSA immobilization | 201088 |
Coflow-Winding | SiO2 | 1–5 μm | Sphere | Mesopore (4.8 nm) | N/A | 201089 |
Coflow-Winding | SiO2 | 1–15 μm | Sphere | Mesopore (4.8 nm) | N/A | 201090 |
Flow-focusing | QDs@SiO2 | ~5 μm | Sphere | Hollow | Ultrasound image; lysozyme immobilization | 201091 |
Coflow and flow-focusing | SiO2 | 29 μm | Sphere | Hollow | N/A | 201092 |
T junction-Winding | SiO2@Au | 177–260 nm | Sphere | Solid | N/A | 201093 |
Y junction-cross junction | SiO2 | 63 nm | Sphere | Solid | N/A | 201146 |
Flow-focusing | SiO2 | 7–50 μm | Doughnut | Solid | N/A | 201194 |
Coflow | Chitosan@TS-1 | 200–600 μm | Sphere | Macropore | N/A | 201195 |
Coflow | SiO2-ETPTA@Ag | 77 μm | Sphere | Solid | BT SERS detection | 201196 |
Coflow | SiO2 | 100–200 μm | Sphere | Hollow; mesopore (2–38 nm) | N/A | 201197 |
Coflow | SiO2@TiO2 | 100–300 μm | Sphere | Solid | N/A | 201198 |
Coflow | Fe2O3@SiO2@Pt | 100 μm | Sphere | Mesopore (18 nm) | IBA oxidation | 201248 |
Flow-focusing | SiO2-FITC | 50–350 nm | Sphere | Solid | N/A | 201299 |
Flow-focusing | SiO2 | 1.4–14.6 μm | Sphere | Hollow; mesopore (7.44 nm) | N/A | 2012100 |
Coflow | SiO2-HDDA | ~0.5 μm | Patchy | Mesopore | N/A | 2012101 |
Cross junction | SiO2 | 7.7 μm | Sphere | Mesopore (3.4–6 nm) | N/A | 2013102 |
Flow-focusing | SiO2-lipid | ~25 μm | Sphere | Mesopore (13.4 nm) | FFB, FSM, MTX, and RTD drug loading | 2013103 |
Coflow | SiO2-Chitosan | 420 μm | Sphere | Mesopore (<5 nm) | Cu(II) adsorption | 2013104 |
Coflow | SiO2-Fe3O4 | 150 μm | Sphere | Mesopore | Optical encoding | 2013105 |
T junction | SiO2@Au | 230 nm | Sphere | Solid | N/A | 2013106 |
T junction | SiO2 | ~100 μm | Raspberry-like | Solid | N/A | 2013107 |
T junction | SiO2 | 90–185 μm | Sphere; filbert-like | Solid; hollow | N/A | 2014108 |
Coflow and flow-focusing | SiO2 | ~200 μm | Sphere; disk | Mesopore | N/A | 2014109 |
Coflow | SiO2-PEGDA | ~200–1000 μm | Rod; cuboid; disk | Solid | Optical encoding | 2014110 |
Coflow and flow-focusing | SiO2-Dextran | 150–400 nm | Sphere | Mesopore | PTX, SFN, and MTX drug loading | 2015111 |
T junction | SiO2@Fe2O3 | ~100 nm | Sphere | Solid | N/A | 2015112 |
T junction | SiO2@Au | ~175 nm | Sphere | Solid | N/A | 2015113 |
Coflow and flow-focusing | SiO2-PEGDA | ~100–150 nm (diameter) | Fiber | Macropore | N/A | 2016114 |
Y junction and T junction | SiO2-Cell | 1.3–2.9 mm | Sphere | Solid | E. coli encapsulation | 2016115 |
T junction | SiO2; Au@SiO2 | ~100–350 nm | Sphere | Solid (Au@SiO2); Mesopore (SiO2) | N/A | 2016116 |
Slit interdigital | SiO2-FITC | 10–65 nm | Sphere | Solid | N/A | 2017117 |
T junction | SiO2-Fe3O4 | 260 μm | Sphere | Mesopore | OTA adsorption | 2017118 |
Flow-focusing | SiO2 | ~10–30 μm | Sphere | Hollow; mesopore (5.9 nm) | N/A | 2017119 |
T junction | SiO2 | 187 μm | Sphere | Mesopore-macropore | DEX drug loading | 2018120 |
Cross junction | SiO2-PCL | ~50 μm | Sphere | Solid; macropore | SOD and CAT immobilization | 2018121 |
Coflow | SiO2-PLGA | ~200 μm | Sphere | Hollow; mesopore | DFO drug loading | 2018122 |
Cross junction | PDT@SiO2 | ~90 μm | Sphere | Solid | N/A | 2018123 |
Abbreviations: BSA: Bovine serum albumin; BT: Benzenethiol; CAT: Chloramphenicol acetyltransferase; DEX: Dexamethasone; DFO: Deferoxamine; ETPTA: Ethoxylated trimethylolpropane triacrylate; FFB: Fenofibrate; FITC: Fluorescein isothiocyanate; FSM: Furosemide; HDDA: 1,6-hexanediol diacrylate; IBA: 4-isopropyl benzaldehyde; MTX: Methotrexate; N/A: Not Applicable; OTA: Ochratoxin A; PCL: Polycaprolactone; PDT: Poly(1,10-decanediol dimethacrylate-co-trimethoxysillyl propyl methacrylate); PEGDA: Poly(ethylene glycol) diacrylate; PLGA: Poly(lactic-co-glycolic acid); PTX: Paclitaxel; QDs: Quantum dots; RTD: Ranitidine; SERS: Surface-enhanced Raman scattering; SFN: Sorafenib; SOD: Superoxide dismutase; TS-1: Titanium silicate molecular sieves.